GLUE - Monte Rosa Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 19.57		 Change
 ⇓ -0.02   (-0.10%)		 Volume
  801,225
Open
 19.83		 High
 20.02		 Low
 19.26
8EMA (Daily)
 20.06		 40EMA (Daily)
 19.70		 50EMA (Daily)
 19.03		 STO (Daily)
 8.063		 MACD Hist (Daily)
 -0.420
8EMA (Weekly)
 19.708		 40EMA (Weekly)
 12.84		 50EMA (Weekly)
 11.79		 STO (Weekly)
 68.842		 MACD Hist (Weekly)
 -0.295
Company Profile
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com